Compare ALEMBIC PHARMA with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs NEULAND LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA NEULAND LABS ALEMBIC PHARMA/
NEULAND LABS
 
P/E (TTM) x 16.8 69.5 24.1% View Chart
P/BV x 6.7 2.5 268.6% View Chart
Dividend Yield % 0.6 0.1 392.9%  

Financials

 ALEMBIC PHARMA   NEULAND LABS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
NEULAND LABS
Mar-20
ALEMBIC PHARMA/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs664754 88.1%   
Low Rs412247 166.8%   
Sales per share (Unadj.) Rs208.7594.5 35.1%  
Earnings per share (Unadj.) Rs31.012.6 245.4%  
Cash flow per share (Unadj.) Rs37.137.0 100.3%  
Dividends per share (Unadj.) Rs5.502.00 275.0%  
Dividend yield (eoy) %1.00.4 255.7%  
Book value per share (Unadj.) Rs144.2553.4 26.1%  
Shares outstanding (eoy) m188.5212.83 1,469.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.60.8 306.3%   
Avg P/E ratio x17.439.6 43.8%  
P/CF ratio (eoy) x14.513.5 107.3%  
Price / Book Value ratio x3.70.9 412.6%  
Dividend payout %17.715.8 112.1%   
Avg Mkt Cap Rs m101,4616,421 1,580.2%   
No. of employees `000NA1.3 0.0%   
Total wages/salary Rs m7,4671,236 604.3%   
Avg. sales/employee Rs ThNM5,949.4-  
Avg. wages/employee Rs ThNM963.8-  
Avg. net profit/employee Rs ThNM126.4-  
INCOME DATA
Net Sales Rs m39,3477,627 515.9%  
Other income Rs m9439 241.4%   
Total revenues Rs m39,4417,666 514.5%   
Gross profit Rs m8,7361,019 857.4%  
Depreciation Rs m1,152313 368.4%   
Interest Rs m184216 85.3%   
Profit before tax Rs m7,493529 1,415.9%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568367 427.0%   
Profit after tax Rs m5,844162 3,605.4%  
Gross profit margin %22.213.4 166.2%  
Effective tax rate %20.969.4 30.2%   
Net profit margin %14.92.1 698.9%  
BALANCE SHEET DATA
Current assets Rs m19,5775,152 380.0%   
Current liabilities Rs m14,8963,576 416.5%   
Net working cap to sales %11.920.7 57.6%  
Current ratio x1.31.4 91.2%  
Inventory Days Days90105 85.4%  
Debtors Days Days4591 49.9%  
Net fixed assets Rs m27,0973,969 682.8%   
Share capital Rs m377129 292.2%   
"Free" reserves Rs m26,8116,971 384.6%   
Net worth Rs m27,1887,100 383.0%   
Long term debt Rs m4,993774 645.3%   
Total assets Rs m47,77812,310 388.1%  
Interest coverage x41.73.5 1,207.7%   
Debt to equity ratio x0.20.1 168.5%  
Sales to assets ratio x0.80.6 132.9%   
Return on assets %12.63.1 411.1%  
Return on equity %21.52.3 941.5%  
Return on capital %23.69.5 249.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,4535,187 375.0%   
Fx outflow Rs m6,0651,593 380.8%   
Net fx Rs m13,3883,594 372.5%   
CASH FLOW
From Operations Rs m8,120573 1,416.0%  
From Investments Rs m-7,556-487 1,552.2%  
From Financial Activity Rs m590-55 -1,077.4%  
Net Cashflow Rs m1,15333 3,537.7%  

Share Holding

Indian Promoters % 74.1 36.3 204.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 63.7 4.6%  
FIIs % 9.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 63.7 21.8%  
Shareholders   49,328 12,705 388.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SANOFI INDIA  ABBOTT INDIA  STRIDES PHARMA SCIENCE  CIPLA  TORRENT PHARMA  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 25, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS